Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3 Testicular Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Motor Activity 1 Hyperthermia 1 Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Carcinoma 1

Interventions

Carboplatin 7 Pemetrexed 5 pembrolizumab 4 Gemcitabine 4 osimertinib 3 Sorafenib 3 Paclitaxel 3 Interleukin-2 3 Cyclophosphamide 3 Cisplatin 3 seocalcitol 2 selinexor 2 patritumab 2 liposomal doxorubicin 2 interferon gamma-1b 2 fludarabine 2 Sunitinib 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Irinotecan 2 Erlotinib Hydrochloride 2 DNA 2 Celecoxib 2 Capecitabine 2 Bleomycin 2 Bevacizumab 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 volociximab 1 thioredoxin reductase inhibitor AM12 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Carcinoma × Control Groups × Clear all

NCT04104334 2021-10-08

CHIPNOL

Ciusss de L'Est de l'Île de Montréal

Phase NA Terminated

Gastrointestinal

Hyperthermia, Carcinoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡